Stock TRVX CIRCIO HOLDING ASA
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Circio Holding ASA

Equities

TRVX

NO0013033795

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-04-30 am EDT 		5-day change 1st Jan Change
2.5 NOK +4.17% Intraday chart for Circio Holding ASA -4.58% -65.28%
Apr. 25 Circio Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 17 Circio Establishes In Vivo Proof-of-Concept for Circular RNA Platform MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Circio Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Circio Establishes In Vivo Proof-of-Concept for Circular RNA Platform
MT
Circio Terminates Cancer Vaccine License Deal in China
MT
Circio Announces in Vivo Proof-Of-Concept for Its circVec circular RNA Platform Technology and Reinforced Gene Therapy Focus
CI
Circio Holding ASA Terminates TG01 Cancer Vaccine License Option Agreement with IOVaxis therapeutics in China for Non-Payment
CI
Circio Partner Exercises Option to License Cancer Vaccine in China
MT
Circio Holding ASA Announces Partner IOVaxis Therapeutics Exercises the Option for an Exclusive License to Mutant RAS Cancer Vaccine TG01 in China
CI
Circio Holding ASA Announces Dosing of First Patient in the Collaborative Phase 2 Trial Sponsored by Georgetown University
CI
Atlas Special Opportunities Converts NOK1 Million of Circio Convertible Bonds
MT
Circio Partner Files Investigational New Drug Application for Cancer Vaccine in China
MT
IOVaxis Therapeutics Files Updated TG01 Investigational New Drug Application with the Chinese National Medical Products Administration
CI
Circio Holding ASA Announces Completion of Planned Safety Review and Opening for Full Enrollment of TG01 Study At Oslo University Hospital
CI
Circio Joins Collaboration to Test the Combination of TG01 Vaccination with Daratumumab and Nivolumab in Immunotherapy-Resistant Patients with Mutant RAS Cancers
CI
Circio, Neoregen Biotech Enter Research Partnership on Circular RNA Therapeutics
MT
Circio Holding ASA and Neoregen Biotech Enter Collaboration for Delivery of Novel Circular Rna Therapeutics Using Nict Technology
CI
Circio Holding Asa Announces Oncos-102 Mesothelioma Study Published in Journal for Immunotherapy of Cancer
CI
Circio Holding ASA Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Targovax ASA Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Targovax ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
CI
Targovax Obtains Regulatory Clearance For Clinical Trial Of Multiple Myeloma Vaccine
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TRVX Stock
  4. News Circio Holding ASA
  5. Highlights